A Patient’s Perspective on Hemophilia

References 

1. AuBuchon JP , Birkmeyer JD , Busch MP . Safety of the blood supply in the United States . Ann Intern Med . 1997;127:904–909
   • MEDLINE
2. Llewelyn CA , Hewitt PE , Knight RSG , Amar K , Cousens S , Mackenzie J , et al.   Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion . Lancet . 2004;363:417–421
   • Abstract
   • Full Text
   • Full-Text PDF (88 KB)
   • CrossRef
3. Peden AH , Head MW , Ritchie DL , Bell JE , Ironside JW . Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient . Lancet . 2004;364:527–529
   • Abstract
   • Full Text
   • Full-Text PDF (189 KB)
   • CrossRef
4. Ironside JW . The spectrum of safety (variant Creutzfeldt-Jakob disease in the United Kingdom) . Semin Hematol . 2003;40(suppl 3):16–22
   • Abstract
   • Full-Text PDF (3449 KB)
   • CrossRef
5. McCullough J , Anderson D , Brookie D , Bouchard JP , Fergusson D , Joly J , et al.   Consensus conference on vCJD screening of blood donors (report of the panel) . Transfusion . 2004;44:675–683
6. Farraguia A . Risk of variant Creuzfeldt-Jakob disease from factor concentrates (current perspectives) . Haemophilia . 2002;3:230–235
7. Evatt BL , Farrugia A , Shapiro AD , Wilde JT . Haemophilia 2002 (Emerging risks of treatment) . Haemophilia . 2002;3:221–229